Page last updated: 2024-08-21

sapropterin and Aortic Diseases

sapropterin has been researched along with Aortic Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al Haj Zen, A; Channon, KM; Chuaiphichai, S; Crabtree, MJ; Douglas, G; Hale, AB; McNeill, E; Patel, J; Rashbrook, VS; Trelfa, L1
Alp, NJ; Channon, KM; Cheng, A; Crabtree, MJ; Douglas, G; Hale, AB; Khoo, J; McNeill, E; O'Neill, CA; Schmidt, TS1
Alp, NJ; Channon, KM; Choudhury, RP; Khoo, J; McAteer, MA1
Croatt, AJ; d'Uscio, LV; Katusic, ZS; Lam, CF; Nath, KA; Peterson, TE; Richardson, DM1

Other Studies

4 other study(ies) available for sapropterin and Aortic Diseases

ArticleYear
Roles for endothelial cell and macrophage Gch1 and tetrahydrobiopterin in atherosclerosis progression.
    Cardiovascular research, 2018, 08-01, Volume: 114, Issue:10

    Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Biopterins; Blood Pressure; Disease Models, Animal; Disease Progression; Endothelial Cells; Female; Foam Cells; GTP Cyclohydrolase; Macrophages; Male; Mice, Knockout, ApoE; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Plaque, Atherosclerotic; Reactive Oxygen Species; Vascular Cell Adhesion Molecule-1; Vasoconstriction; Vasodilation

2018
Tetrahydrobiopterin supplementation reduces atherosclerosis and vascular inflammation in apolipoprotein E-knockout mice.
    Clinical science (London, England : 1979), 2010, May-06, Volume: 119, Issue:3

    Topics: Administration, Oral; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Biopterins; Chemotaxis, Leukocyte; Disease Progression; Drug Administration Schedule; Drug Evaluation, Preclinical; Endothelium, Vascular; Hemodynamics; Lipids; Male; Mice; Mice, Knockout; RNA, Messenger; Tissue Distribution; Vascular Cell Adhesion Molecule-1

2010
Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:3

    Topics: Animals; Aorta; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Biopterins; Coenzymes; Crosses, Genetic; Cyclic GMP; Diet, Atherogenic; Endothelium, Vascular; GTP Cyclohydrolase; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Nitric Oxide; Organ Specificity; Receptor, TIE-2; Recombinant Fusion Proteins; Superoxides; Vasodilation

2004
Increased blood flow causes coordinated upregulation of arterial eNOS and biosynthesis of tetrahydrobiopterin.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 290, Issue:2

    Topics: Animals; Aorta; Aortic Diseases; Arteriovenous Fistula; Biopterins; Blotting, Western; Cyclic GMP; GTP Cyclohydrolase; Hemodynamics; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Up-Regulation; Vasomotor System; Vena Cava, Inferior

2006